{"id":2211,"date":"2026-07-20T11:35:20","date_gmt":"2026-07-20T11:35:20","guid":{"rendered":"https:\/\/navigotechsolutions.com\/blog\/nvidia-and-bristol-myers-build-ai-factory-what-indian-pharma-must-know\/"},"modified":"2026-07-20T11:35:22","modified_gmt":"2026-07-20T11:35:22","slug":"nvidia-and-bristol-myers-build-ai-factory-what-indian-pharma-must-know","status":"publish","type":"post","link":"https:\/\/navigotechsolutions.com\/blog\/nvidia-and-bristol-myers-build-ai-factory-what-indian-pharma-must-know\/","title":{"rendered":"NVIDIA and Bristol Myers Build AI Factory: What Indian Pharma Must Know"},"content":{"rendered":"<style>\n:root{--primary-blue:#1e90ff;--deep-blue:#003C8F;--accent-orange:#1e90ff;--neutral-bg:#F9F9F9;--neutral-white:#FFFFFF;--text-charcoal:#2C2C2C;--text-grey:#555555;--light-blue-bg:#EDF5FF;}\nbody{margin:0;padding:0;font-family:'Open Sans',sans-serif;background-color:var(--neutral-bg);color:var(--text-charcoal);line-height:1.6;}\na{color:var(--primary-blue);font-weight:700;text-decoration:none;border-bottom:2px solid var(--accent-orange);transition:all .3s ease;}\na:hover{color:var(--deep-blue);border-bottom-color:var(--primary-blue);background-color:var(--light-blue-bg);}\n.navigo-container{font-family:'Open Sans',sans-serif;background-color:var(--neutral-bg);background-image:radial-gradient(#e5e5e5 1px,transparent 1px);background-size:20px 20px;max-width:900px;margin:40px auto;padding:40px;border-radius:20px;box-shadow:0 10px 30px rgba(0,0,0,.05);position:relative;overflow:hidden;}\n.navigo-shape-top-right{position:absolute;top:-50px;right:-50px;width:150px;height:150px;background:var(--primary-blue);border-radius:50%;opacity:.1;z-index:0;}\n.navigo-shape-bottom-left{position:absolute;bottom:-50px;left:-50px;width:200px;height:200px;background:var(--accent-orange);border-radius:50%;opacity:.05;z-index:0;}\n.navigo-hero{background:var(--neutral-white);padding:45px;border-radius:15px;box-shadow:0 4px 15px rgba(0,0,0,.03);border-left:6px solid var(--primary-blue);margin-bottom:40px;position:relative;z-index:1;}\n.navigo-logo{font-family:'Montserrat',sans-serif;font-weight:800;background:var(--light-blue-bg);padding:6px 12px;border-radius:4px;color:var(--deep-blue);letter-spacing:1px;font-size:1rem;margin-bottom:18px;display:inline-block;}\n.navigo-hero h1{font-family:'Montserrat',sans-serif;font-size:2rem;margin:0 0 12px;color:var(--text-charcoal);line-height:1.3;}\n.navigo-hero p{font-size:1.05rem;color:var(--text-grey);line-height:1.7;margin:0 0 12px;max-width:760px;}\n.navigo-article{background:var(--neutral-white);padding:35px;border-radius:12px;border:1px solid #e5e5e5;line-height:1.9;font-size:1.06rem;color:var(--text-grey);position:relative;z-index:1;}\n.navigo-article h2{font-family:'Montserrat',sans-serif;color:var(--deep-blue);font-size:1.6rem;margin-top:34px;margin-bottom:12px;}\n.navigo-article h3{font-family:'Montserrat',sans-serif;color:var(--text-charcoal);font-size:1.2rem;margin-top:22px;margin-bottom:8px;}\n.navigo-article p{margin-bottom:14px;}\n.navigo-article ul{margin-left:18px;margin-bottom:14px;}\n.navigo-article table{width:100%;border-collapse:collapse;margin:20px 0;}\n.navigo-article th,.navigo-article td{border:1px solid #e5e5e5;padding:12px;text-align:left;}\n.navigo-article th{background-color:#f2f2f2;color:var(--deep-blue);}\n.key-takeaways{background:var(--light-blue-bg);border-left:6px solid var(--primary-blue);padding:18px 22px;border-radius:8px;margin:28px 0;}\n.toc{background:#fafafa;border:1px solid #eee;padding:20px;border-radius:8px;margin:25px 0;}\n.toc strong{display:block;margin-bottom:10px;font-family:'Montserrat',sans-serif;color:var(--deep-blue);}\n.toc ul{list-style-type:none;padding-left:0;margin:0;}\n.toc li{margin-bottom:8px;padding-left:15px;position:relative;}\n.toc li::before{content:\"\u2022\";color:var(--primary-blue);position:absolute;left:0;top:0;}\n.navigo-faq-header{text-align:center;margin-top:42px;margin-bottom:22px;}\n.navigo-faq-header h2{font-family:'Montserrat',sans-serif;font-size:1.9rem;color:var(--text-charcoal);}\n.navigo-faq-details{background:var(--neutral-white);margin-bottom:12px;border-radius:8px;border:1px solid #e5e5e5;overflow:hidden;position:relative;z-index:1;}\n.navigo-faq-summary{padding:16px 20px;font-family:'Montserrat',sans-serif;font-weight:700;color:var(--deep-blue);cursor:pointer;display:flex;justify-content:space-between;align-items:center;list-style:none;}\n.navigo-faq-summary::after{content:'';width:10px;height:10px;border-right:3px solid var(--primary-blue);border-bottom:3px solid var(--primary-blue);transform:rotate(45deg);flex-shrink:0;}\n.navigo-faq-details[open] .navigo-faq-summary::after{transform:rotate(-135deg);}\n.navigo-faq-answer{padding:0 20px 18px;color:var(--text-grey);}\n.navigo-footer{margin-top:36px;padding-top:22px;border-top:2px solid #eee;text-align:center;color:var(--text-grey);font-size:.95rem;position:relative;z-index:1;}\n@media(max-width:768px){.navigo-container{padding:20px;margin:0;border-radius:0;}.navigo-hero{padding:25px;}.navigo-article{padding:20px;font-size:1rem;}.navigo-shape-top-right,.navigo-shape-bottom-left{display:none;}}\n<\/style>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Montserrat:wght@400;700;800&#038;family=Open+Sans:wght@400;600;700&#038;display=swap\" rel=\"stylesheet\">\n<div class=\"navigo-container\">\n<div class=\"navigo-shape-top-right\"><\/div>\n<div class=\"navigo-shape-bottom-left\"><\/div>\n<div class=\"navigo-hero\">\n<div class=\"navigo-logo\">NaviGo Tech Solutions<\/div>\n<h1>NVIDIA and Bristol Myers Build AI Factory: What Indian Pharma Must Know<\/h1>\n<p>In May 2026, Bristol Myers Squibb (BMS) announced it is building the life science industry&#8217;s most advanced <strong>AI factory on NVIDIA Vera Rubin<\/strong>. This is not just about faster computers. It is about fundamentally changing how drugs are discovered, tested, and brought to market. For Indian pharma companies, this signals a clear deadline to adopt similar AI infrastructure or risk falling behind globally.<\/p>\n<p>This guide covers:<\/p>\n<ul>\n<li>What the NVIDIA-BMS AI factory actually does<\/li>\n<li>Why it matters for Indian pharmaceutical and biotech firms<\/li>\n<li>Step-by-step actions for Indian companies to adopt AI in R&#038;D<\/li>\n<li>Common pitfalls and how to avoid them<\/li>\n<li>A comparison of AI tools available for pharma today<\/li>\n<\/ul>\n<p>Read on to understand how this global shift in drug discovery can shape your business strategy in 2026 and beyond.<\/p>\n<\/p><\/div>\n<div class=\"navigo-article\">\n<div class=\"key-takeaways\"><strong>What You&#8217;ll Learn:<\/strong><\/p>\n<ul>\n<li>How BMS achieved 55% cost savings using NVIDIA&#8217;s AI factory for drug development<\/li>\n<li>The specific AI models and infrastructure (DGX SuperPOD, Claude AI) used by BMS<\/li>\n<li>Practical steps Indian pharma companies can take to implement similar AI strategies<\/li>\n<li>Common mistakes to avoid when integrating AI into pharmaceutical R&#038;D<\/li>\n<\/ul><\/div>\n<div class=\"toc\"><strong>Table of Contents<\/strong><\/p>\n<ul>\n<li><a href=\"#section-1\">What Is the NVIDIA-Bristol Myers AI Factory?<\/a><\/li>\n<li><a href=\"#section-2\">Why This AI Factory Matters for Indian Pharma<\/a><\/li>\n<li><a href=\"#section-3\">How Indian Pharma Can Build Their Own AI Factory: A Step-by-Step Guide<\/a><\/li>\n<li><a href=\"#section-4\">Common Mistakes Indian Pharma Makes When Adopting AI<\/a><\/li>\n<li><a href=\"#section-5\">AI Tools Comparison: What Works for Indian Pharma in 2026<\/a><\/li>\n<\/ul><\/div>\n<h2 id=\"section-1\">What Is the NVIDIA-Bristol Myers AI Factory?<\/h2>\n<p>The partnership between NVIDIA and Bristol Myers Squibb is not a small pilot project. It is a full-scale AI factory built on <strong>NVIDIA DGX SuperPOD<\/strong>, a supercomputing platform designed for high-performance computing. This platform became operational in March 2024 and has since transformed how BMS approaches drug discovery and development.<\/p>\n<p>BMS uses this AI factory to train <strong>foundational AI models<\/strong> on hundreds of thousands of clinical trial images. These models help predict patient outcomes, especially in immuno-oncology. The system also uses large language models (LLMs) and transformers to analyse diverse clinical trial data\u2014genomics, lifestyle factors, and treatment history\u2014to predict how patients will respond to treatments.<\/p>\n<p>The results speak for themselves. BMS reported <strong>55% overall cost savings<\/strong> compared to its previous computational model. The company also deployed <strong>Anthropic&#8217;s Claude AI model<\/strong> in May 2026 to speed up drug discovery and enterprise-wide workflows. Claude helps researchers process and summarise vast amounts of scientific literature, saving weeks of manual work.<\/p>\n<p>For Indian pharma, these numbers are a wake-up call. If a global giant can cut costs by more than half using AI, Indian companies must seriously evaluate how they can achieve similar efficiency gains. For a practical guide on integrating AI into your overall marketing and business strategy, read our overview of <a href=\"https:\/\/navigotechsolutions.com\/services.html#digital-marketing\">AI Digital Marketing<\/a> services.<\/p>\n<h2 id=\"section-2\">Why This AI Factory Matters for Indian Pharma<\/h2>\n<h3>India is the pharmacy of the world, but it needs to move up the value chain<\/h3>\n<p>India already has over 55 Global Capability Centres (GCCs) in pharma and employs more than 3 lakh people in the sector. However, most Indian companies still focus on generic manufacturing and contract research. The NVIDIA-BMS model shows that AI-driven drug discovery is the next frontier. Companies that do not invest in AI infrastructure will struggle to compete in high-value areas like oncology and neurodegeneration research.<\/p>\n<h3>Cost savings can be dramatic<\/h3>\n<p>BMS saved 55% on computational costs. For Indian pharma companies operating on thinner margins, these savings can free up capital for other critical investments. An AI factory can handle tasks like automated lesion segmentation, medical imaging analysis, and patient outcome prediction at a fraction of the cost of traditional methods.<\/p>\n<h3>Talent and infrastructure are ready, but action is needed<\/h3>\n<p>India produces world-class AI and data science talent. However, many pharma companies still rely on outdated IT systems. The good news is that NVIDIA&#8217;s DGX SuperPOD is now accessible as a service, meaning companies do not need to build their own hardware from scratch. Indian firms can partner with NVIDIA or other cloud providers to access similar computing power.<\/p>\n<p>To get started with AI strategy in your organisation, consider exploring <a href=\"https:\/\/navigotechsolutions.com\/services.html#consulting\">AI Strategy Consulting<\/a> services that can help you map out a practical roadmap.<\/p>\n<p>Indian companies that move now can leapfrog competitors. The window is narrow. Global pharma is already doubling down on AI. According to Reuters, the pharma sector is slashing costs and timelines with AI. Indian firms must follow suit or risk losing their position as the preferred partner for global drug development.<\/p>\n<figure class=\"wp-block-image size-large\" style=\"margin: 32px 0; text-align: center;\">\n                      <img decoding=\"async\" src=\"https:\/\/navigotechsolutions.com\/blog\/wp-content\/uploads\/2026\/07\/nvidia-bristol-myers-ai-factory-indian-pharma-1.jpg\" alt=\"list-based infographic of why this matters, numbered colored icons, clean white background, premium colours. The infographic shows four numbered cards: 1. Cost Savings (55% icon with a coin), 2. Faster Timelines (clock icon), 3. Better Patient Outcomes (heart icon), 4. Competitive Advantage (trophy icon). Each card has a short label in clear sans-serif font.\" style=\"border-radius: 12px; max-width: 100%; height: auto; box-shadow: 0 4px 15px rgba(0,0,0,0.08);\" \/><br \/>\n                    <\/figure>\n<h2 id=\"section-3\">How Indian Pharma Can Build Their Own AI Factory: A Step-by-Step Guide<\/h2>\n<p>You do not need to replicate the entire NVIDIA DGX SuperPOD setup from day one. Here is a practical roadmap for Indian pharma companies of any size.<\/p>\n<ul>\n<li><strong>Step 1: Audit your current computational infrastructure.<\/strong> List all existing hardware, software, and data storage capabilities. Identify bottlenecks in data processing, especially for medical imaging and genomics data. Many Indian companies have siloed data that first needs to be centralised.<\/li>\n<li><strong>Step 2: Start with a focused AI pilot project.<\/strong> Choose one area where AI can deliver quick wins. For example, automate lesion segmentation in radiology images or use LLMs to summarise clinical trial literature. BMS started with a smaller NVIDIA cluster three years before scaling up.<\/li>\n<li><strong>Step 3: Partner with AI platform providers.<\/strong> You do not need to build from scratch. NVIDIA offers DGX SuperPOD as a cloud service. Similarly, platforms like Anthropic&#8217;s Claude or OpenAI&#8217;s models can be accessed via API. Evaluate which provider aligns with your data privacy and compliance needs.<\/li>\n<li><strong>Step 4: Train your teams on AI workflows.<\/strong> Invest in upskilling your R&#038;D and data science teams. Running foundational models requires understanding of self-supervised learning, transformers, and medical imaging frameworks like NVIDIA MONAI. Consider hiring a dedicated AI lead for your pharma division.<\/li>\n<li><strong>Step 5: Scale gradually.<\/strong> Once your pilot shows measurable results (like reduced time for image analysis or cost savings), expand to more use cases. BMS expanded from oncology imaging to neurodegeneration and genomics analysis. Set clear KPIs for each phase.<\/li>\n<\/ul>\n<p>If you are also looking to market your pharma products more effectively, understanding <a href=\"https:\/\/navigotechsolutions.com\/blog\/ppc-advertising-in-2026-how-to-run-high-roi-campaigns-with-the-best-ppc-company-in-chennai\/\">PPC advertising in 2026<\/a> can help you reach doctors and hospitals with precision.<\/p>\n<h2 id=\"section-4\">Common Mistakes Indian Pharma Makes When Adopting AI<\/h2>\n<h3>Mistake 1: Trying to do everything at once<\/h3>\n<p>Many Indian companies rush to deploy AI across all departments simultaneously. This leads to fragmented systems, poor data integration, and low adoption. Start small. Pick one high-impact use case, prove the value, then scale. BMS started with a smaller cluster and expanded organically.<\/p>\n<h3>Mistake 2: Ignoring data quality and standardisation<\/h3>\n<p>AI models are only as good as the data they train on. Indian hospitals and labs often have non-standardised data formats, missing fields, and low-resolution images. Before investing in AI infrastructure, clean and standardise your existing datasets. This is the most time-consuming but critical step.<\/p>\n<h3>Mistake 3: Overlooking regulatory compliance<\/h3>\n<p>The Indian pharmaceutical sector is heavily regulated. Using AI in drug discovery and clinical trials must comply with CDSCO and global regulatory standards. Ensure your AI models are explainable and auditable. Black-box models that cannot be validated will fail regulatory scrutiny.<\/p>\n<h3>Mistake 4: Underinvesting in talent retention<\/h3>\n<p>India produces excellent AI talent, but the demand is high. Many pharma companies lose their AI experts to tech giants and startups. Build a strong career path for your AI team. Offer competitive compensation, access to cutting-edge tools, and opportunities to publish research. This reduces attrition and builds institutional knowledge.<\/p>\n<p>For a broader view of how AI is transforming business workflows, read our analysis of <a href=\"https:\/\/navigotechsolutions.com\/blog\/gpt-5-2-explained-for-business-coding-and-productivity\/\">GPT-5.2 for business<\/a> and how it can improve productivity in your operations.<\/p>\n<figure class=\"wp-block-image size-large\" style=\"margin: 32px 0; text-align: center;\">\n                      <img decoding=\"async\" src=\"https:\/\/navigotechsolutions.com\/blog\/wp-content\/uploads\/2026\/07\/nvidia-bristol-myers-ai-factory-indian-pharma-2.jpg\" alt=\"2-column comparison grid, Mistakes (red X) vs Best Practices (green check), clean white background. Left column lists four mistakes with red X icons: 1. Trying everything at once, 2. Ignoring data quality, 3. Overlooking compliance, 4. Underinvesting in talent. Right column lists corresponding best practices with green check icons: 1. Start with one pilot, 2. Standardise data first, 3. Ensure explainability, 4. Build career paths. Premium professional colours, no clutter.\" style=\"border-radius: 12px; max-width: 100%; height: auto; box-shadow: 0 4px 15px rgba(0,0,0,0.08);\" \/><br \/>\n                    <\/figure>\n<h2 id=\"section-5\">AI Tools Comparison: What Works for Indian Pharma in 2026<\/h2>\n<p>There are several AI tools and platforms available for Indian pharma companies. Below is a comparison of the most relevant ones based on cost, ease of use, and applicability to drug discovery and development. Indian companies should evaluate these options based on their specific needs and budget.<\/p>\n<p>For example, NVIDIA DGX SuperPOD is ideal for large-scale medical imaging, while Anthropic Claude is better for text-heavy tasks like literature review. Indian firms can also consider hybrid approaches that combine multiple tools.<\/p>\n<table>\n<thead>\n<tr>\n<th>Tool \/ Platform<\/th>\n<th>Best For<\/th>\n<th>Cost (Approx.)<\/th>\n<th>Ease of Implementation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NVIDIA DGX SuperPOD<\/td>\n<td>Large-scale medical imaging, genomics<\/td>\n<td>High (custom quote)<\/td>\n<td>Medium (requires skilled team)<\/td>\n<\/tr>\n<tr>\n<td>Anthropic Claude AI<\/td>\n<td>Literature review, document analysis<\/td>\n<td>Pay-per-use (API)<\/td>\n<td>Easy (API integration)<\/td>\n<\/tr>\n<tr>\n<td>NVIDIA MONAI<\/td>\n<td>Medical image analysis, lesion segmentation<\/td>\n<td>Free (open source)<\/td>\n<td>Medium (needs ML expertise)<\/td>\n<\/tr>\n<tr>\n<td>Google Cloud Healthcare API + Vertex AI<\/td>\n<td>Data standardisation, predictive modelling<\/td>\n<td>Pay-per-use<\/td>\n<td>Medium (good documentation)<\/td>\n<\/tr>\n<tr>\n<td>Amazon SageMaker + HealthLake<\/td>\n<td>Custom model training, data lake management<\/td>\n<td>Pay-per-use<\/td>\n<td>Medium (requires AWS knowledge)<\/td>\n<\/tr>\n<tr>\n<td>OpenAI GPT-5 series<\/td>\n<td>Generative AI for report writing, summarisation<\/td>\n<td>Pay-per-use (API)<\/td>\n<td>Easy (simple API calls)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For Indian companies on a tight budget, starting with NVIDIA MONAI (free) and adding cloud services like Google Vertex AI can provide a balanced approach. If you need help implementing these tools, our <a href=\"https:\/\/navigotechsolutions.com\/services.html#ai-agents\">AI Agents &#038; Bots<\/a> team can assist with custom integrations and workflow automation.<\/p>\n<\/p><\/div>\n<div style=\"background:linear-gradient(135deg,#25D366 0%,#128C7E 100%);border-radius:12px;padding:24px 28px;margin:32px 0;text-align:center;position:relative;z-index:1;\">\n<p style=\"color:#fff;font-family:'Montserrat',sans-serif;font-weight:800;font-size:1.15rem;margin:0 0 8px;\">Not sure which tool fits your business?<\/p>\n<p style=\"color:rgba(255,255,255,0.9);font-size:0.95rem;margin:0 0 16px;\">Our team at NaviGo Tech Solutions will set it up for you \u2014 free 30-minute strategy call.<\/p>\n<p>  <a href=\"https:\/\/wa.me\/916380853075?text=Hi%2C%20I%20read%20your%20blog%20and%20want%20a%20free%20strategy%20call\" target=\"_blank\" rel=\"noopener\" style=\"background:#fff;color:#128C7E;font-family:&#039;Montserrat&#039;,sans-serif;font-weight:800;padding:12px 28px;border-radius:50px;text-decoration:none;font-size:1rem;border-bottom:none;display:inline-block;\">WhatsApp Us Now \u2014 It&#8217;s Free<\/a>\n<\/div>\n<div class=\"navigo-faq-header\">\n<h2>Frequently Asked Questions<\/h2>\n<\/div>\n<details class=\"navigo-faq-details\">\n<summary class=\"navigo-faq-summary\">What is the NVIDIA-Bristol Myers AI factory?<\/summary>\n<div class=\"navigo-faq-answer\">It is a high-performance computing platform built on NVIDIA DGX SuperPOD. BMS uses it to train AI models on clinical trial images, predict patient outcomes, and automate literature review using Anthropic Claude. It achieved 55% cost savings for BMS.<\/div>\n<\/details>\n<details class=\"navigo-faq-details\">\n<summary class=\"navigo-faq-summary\">How can Indian pharma companies afford similar AI infrastructure?<\/summary>\n<div class=\"navigo-faq-answer\">Indian companies do not need to buy the full DGX SuperPOD. They can start with cloud-based NVIDIA services, use open-source frameworks like MONAI, and scale up gradually. Many providers offer pay-per-use pricing, making it affordable for mid-size firms.<\/div>\n<\/details>\n<details class=\"navigo-faq-details\">\n<summary class=\"navigo-faq-summary\">Will AI replace pharmaceutical researchers in India?<\/summary>\n<div class=\"navigo-faq-answer\">No. AI will augment researchers by automating repetitive tasks like image analysis and literature review. Researchers will focus on higher-value activities like experimental design, validation, and regulatory strategy. Jobs will evolve, not disappear.<\/div>\n<\/details>\n<details class=\"navigo-faq-details\">\n<summary class=\"navigo-faq-summary\">What are the best AI tools for Indian pharma startups?<\/summary>\n<div class=\"navigo-faq-answer\">Startups should begin with open-source tools like NVIDIA MONAI for imaging and Anthropic Claude API for text analysis. Cloud platforms like Google Vertex AI offer scalable options. Avoid heavy upfront hardware investments until you validate a use case.<\/div>\n<\/details>\n<div class=\"navigo-footer\">\n<p>Ready to make your pharma business AI-ready? Start with a free consultation call to see how AI can cut your R&#038;D costs and speed up drug discovery.<\/p>\n<p><a href=\"https:\/\/navigotechsolutions.com\/contact.html\" target=\"_blank\">WhatsApp Us Now \u2014 It&#8217;s Free \u2014 NaviGo Tech Solutions<\/a><\/p>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Learn how Bristol Myers Squibb built an AI factory with NVIDIA, saving 55% in costs. Discover what Indian pharma companies must do to stay competitive in drug discovery.<\/p>\n","protected":false},"author":1,"featured_media":2208,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[216],"tags":[997,1460,991,1459,1465,1462,1461,1146,1463,1464],"class_list":["post-2211","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ai-tools","tag-ai-cost-savings","tag-ai-factory","tag-ai-in-healthcare","tag-bristol-myers-squibb","tag-clinical-trials","tag-drug-discovery","tag-indian-pharma","tag-nvidia","tag-nvidia-dgx-superpod","tag-pharmaceutical-ai"],"jetpack_featured_media_url":"https:\/\/navigotechsolutions.com\/blog\/wp-content\/uploads\/2026\/07\/nvidia-bristol-myers-ai-factory-indian-pharma.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/posts\/2211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/comments?post=2211"}],"version-history":[{"count":1,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/posts\/2211\/revisions"}],"predecessor-version":[{"id":2212,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/posts\/2211\/revisions\/2212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/media\/2208"}],"wp:attachment":[{"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/media?parent=2211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/categories?post=2211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navigotechsolutions.com\/blog\/wp-json\/wp\/v2\/tags?post=2211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}